Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.54SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.29SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.29SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
N.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
P.1.15 (Gamma)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.348SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.575SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
C.26SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Q.4 (Alpha)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.442SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
P.1.1 (Gamma)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
A.2.5.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.600SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
P.1.12 (Gamma)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.525 (Eta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.6 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
P.1.7 (Gamma)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.24 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.45 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.70 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.26.1 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.5 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.108 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.32 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.46.3 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.4.6 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
AY.75.2 (Delta)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
C.37 (Lambda)SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.9.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.6.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.34SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.12SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.9.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BN.1.4.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.58SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XAY.2.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.71SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBC.1.2.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CP.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DN.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CL.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.3.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BN.1.2.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.25SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DB.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CZ.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.1.18SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.1.29SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used